Showing results (41-50 of 3,991) with videos related to
Sort By:
Pageof 400
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1985
Clinical efficacy and safety of long-term diuretic treatment in renal parenchymal hypertensionH Schiffl, P SchollmeyerMinerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 24, 2009
Acute kidney injury as a risk and progression factor for chronic kidney injuryH Schiffl, S LangKlinische Wochenschrift|October 31, 1991
Generation of leukotriene B4 by hemodialyzer membranes: a novel index of biocompatibilityT Strasser, H SchifflBiochimica Et Biophysica Acta|October 1, 1990
Leukotriene B4 is involved in hemodialysis-associated neutropeniaT Strasser, H SchifflInternational Urology and Nephrology|June 1, 2011
Clinical cause of presumed acute tubular necrosis requiring renal replacement therapy and outcome of critically ill patients: post hoc analysis of a prospective 7-year cohort studyH Schiffl, R FischerPflugers Archiv : European Journal of Physiology|November 25, 1977
Induction of Na-K-ATPase in plasma membranes to rat cecum mucosa by diet: time course and kineticsH Schiffl, K LoeschkeCardiology|January 1, 1985
Metabolic consequences of long-term thiazide-based antihypertensive treatment of renal hypertensionH Schiffl, P SchollmeyerBiomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1991
Hemodialysis-related leukotriene B4 generation and neutropenia during calcium channel blockadeH Schiffl, T StrasserEuropean Journal of Medical Research|March 24, 1997
Hypertension induced by recombinant human erythropoietin (rHU-EPO) can be prevented by indomethacin. Pathogenetic role of cytosolic calciumH Schiffl, S M LangInternational Urology and Nephrology|June 20, 2025
Long-term renal consequences of COVID-19. Emerging evidence and unanswered questionsS M Lang, H SchifflPageof 400